Abstract
Equations were derived to describe the time course of drug levels during auto- and heteroinduction under a variety of input conditions. These equations were based on a pharmacokinetic theory of induction which assumes that metabolic clearance increases exponentially to a maximum value and that the rate of this increase is governed by the degradation rate constant of the induced enzyme (k′). Closed form solutions could be obtained only for intravenous single-dose (case I) and multiple-dose (case IV) administration. For each of the other cases, constant-rate intravenous infusion (case III), oral single-dose administration (case II), and multiple-dose administration (case V), an exact solution (not closed form) and an approximation (closed form) were derived. Two sets of equations were derived for each of the five cases to take into consideration the possibility of a latency term (λ).Plots of drug amount X(or concentration C) vs. time (t) were constructed. In case I, a log Xvs. tplot was convex, the slope increasing with time. In case II, Xincreased,reached a peak, and decayed as in case I. In case III (λ > 5In 2V/Q) Creached a preinduction steady state before decreasing to a lower (induced) steady state. When λ=0, Creached a maximum before decreasing to the same induced steady state. The behavior of Cvs. tfor cases IV and V was similar to that for case III. Determination of parameters was attempted in case III. Nonlinear least-square fitting of generated data with 3–9% error yielded reasonable estimates of k′.
Similar content being viewed by others
References
W. H. Pitlick and R. H. Levy. Time-dependent kinetics. I. Exponential auto-induction of carbamazepine in monkeys.J. Pharm. Sci. 66:647–649 (1977).
W. H. Pitlick, R. H. Levy, A. S. Troupin, and J. R. Green. A pharmacokinetic model to describe self-induced decreases in steady state concentrations of carbamazepine.J. Pharm. Sci. 65:642–643 (1976).
R. H. Levy, W. H. Pitlick, A. S. Troupin, and J. R. Green. Pharmacokinetic implications of chronic drug treatment in epilepsy: Carbamazepine. In L. Z. Benet (ed.),The Effect of Disease States on Drug Pharmacokinetics, APhA, Washington, D.C., 1976, Chap. 6, pp. 87–95.
R. H. Levy, A. A. Lai, and M. S. Dumain. Time dependent kinetics. IV. Pharmacokinetic theory of enzyme induction.J. Pharm. Sci. 68:398–399 (1979).
C. M. Berlin and R. T. Schimke. Influence of turnover rates on the responses of enzymes to cortisone.Mol. Pharmacol. 1:149–156 (1965).
P. H. Corbisier and R. H. Levy. Carbamazepine-ethosuximide interaction in rhesus monkeys.APhA Acad. Pharm. Sci. Abstr. 7:163 (1977).
P. H. Corbisier and R. H. Levy. Pharmacokinetics of drug interactions by enzyme induction I. Carbamazepine-valproic acid.APhA Acad. Pharm. Sci. Abstr. 7:134 (1977).
A. A. Lai and R. H. Levy. Pharmacokinetic description of drug interactions by enzyme induction: Carbamazepine-clonazepam in monkeys.J. Pharm. Sci. 68:416–421 (1979).
A. A. Lai, R. H. Levy, and R. E. Cutler. Time-course of interaction between carbamazepine and clonazepam in normal man.Clin. Pharmacol. Ther. 34:316–323 (1978).
M. S. Dumain, The analysis of several continuous time-dependent pharmacokinetic models under single and multiple dose conditions. MS Thesis, University of Washington, 1979.
Author information
Authors and Affiliations
Additional information
This work was supported by NIH Research Contracts N0l-NS-1-2282 and N01-NS-6-2341.
Parts I, II, III, IV, and VI of this series can be found in theJournal of Pharmaceutical Sciences.
Rights and permissions
About this article
Cite this article
Levy, R.H., Dumain, M.S. & Cook, J.L. Time-dependent kinetics. V: Time course of drug levels during enzyme induction (one-compartment model). Journal of Pharmacokinetics and Biopharmaceutics 7, 557–578 (1979). https://doi.org/10.1007/BF01061209
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061209